Clinical Trial Update: A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a vaccine for COPD to reduce episodes of worsening symptoms and assess safety and immune response; study completed with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GlaxoSmithKline vaccine (未 specified)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Respiratory Disorders | Phase 2 | Status: COMPLETED | Results posted: 2021-01-11